Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
car-t immunotherapy
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
abbvie
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
deals
detroit blog main
detroit top stories
eli lilly
gilead sciences
indiana blog main
indiana top stories
johnson & johnson
medicare
merck
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
pembrolizumab keytruda
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
startups
texas blog main
texas top stories
What
drug
bio
companies
nash
news
roundup
adding
approval
approved
bets
biogen’s
biopharmaceutical
boost
cancer
convo
digital
disease
earlier
epidemic
expensive
failures
far
fatty
fda
frenzied
gilead
growing
known
led
littered
liver
merck
million
new
paying
pipeline
price
program
race
remains
Language
Current search:
" car-t immunotherapy "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
